EVALUATION PARAMETERS FOR LOSARTAN POTASSIUM:
Development and evaluation of controlled porosity osmotic pump tablet of losartan potassium
... of Losartan potassium to prolong the release of drug oral ...administration. Losartan potassium is an anti -hypertensive drug and it acts as an angiotension II receptor ...various ...
11
FORMULATION AND EVALUATION OF SUBLINGUAL TABLET OF LOSARTAN POTASSIUM
... Talluri Manjula et al. (2016) made an attempt to develop and evaluate sublingual tablets of Zolpidem Tartrate used for the short-term treatment of insomnia. The tablet was prepared by direct compression technique using ...
13
Formulation and Evaluation of Losartan Potassium and Hydrochlorthiazide Conventional Tablets.
... Dept. of Pharmaceutics 15 J.K.K.M.M.R.F college of pharmacy During granulation, practices and agglomerates are subjected to consolidating forces by action of machine parts and of inter particulate forces. Granulation in ...
118
FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF LOSARTAN POTASSIUM
... of Losartan potassium by direct compression method with starch urea borate was prepared and evaluated for different parameters such as weight uniformity, thickness, hardness, friability, swelling ...
16
FORMULATION AND IN VITRO EVALUATION OF LOSARTAN POTASSIUM MUCOADHESIVE BUCCAL TABLETS
... The Losartan potassium mucoadhesive buccal tablet were prepared using mucoadhesive polymers such as Carbopol 940P, pectin, sodium CMC, Sodium alginate, HPMC K4M, HPMC K15M and HPMC K100M in alone and in ...
6
Formulation and Evaluation of Losartan Potassium Osmotic Controlled Matrix Tablets
... of Losartan potassium an angiotensin II receptor antagonist with anti-hypertensive ...activity. Losartan potassium matrix tablets were prepared by direct compression process using HPMC K 15M ...
9
FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM AND HYDROCHLORTHIAZIDE CONVENTIONAL RELEASE TABLETS
... Processing parameters were shown to affect the growth rate of granules in the high-shear wet granulation. The main objective of granulation is to improve flow properties and compression characteristics of the ...
6
Formulation and evaluation of Losartan Potassium matrix tablets for oral controlled release
... of losartan potassium over a period of 24 ...of losartan potassium from all the formulations (except F2, F3, F8 which showed first order release) are close to zero order and follow diffusion ...
6
DESIGN AND EVALUATION OF LOSARTAN POTASSIUM MATRIX TABLETS WITH NATURAL AND SYNTHETIC POLYMERS
... of Losartan potassium matrix tablets were manufactured under similar conditions to avoid the processing ...various evaluation tests such as weight uniformity, hardness, drug content, friability and ...
6
DEVELOPMENT AND IN-VITRO EVALUATION OF MATRIX-TYPE TRANSDERMAL PATCHES OF LOSARTAN POTASSIUM
... CONCLUSION Transdermal drug delivery systems continue to deliver patients’ increased compliance by providing predictable and reliable therapeutic dosages. The prepared transdermal drug delivery system of Losartan ...
5
FORMULATION AND IN VITRO EVALUATION OF GASTRORETENTIVE BILAYER FLOATING TABLETS OF LOSARTAN POTASSIUM
... Hence formula C was used as immediate layer in all bilayered tablets. The blend of the drug and excipients was evaluated for micrometric properties and were tabulated in Table 3.Angle of repose was found to be between ...
8
Development and In Vitro Evaluation of Sustained Release Matrix Tablets of Losartan Potassium
... of Losartan potassium Sustained release matrix tablet containing 50 mg of Losartan potassium were prepared by direct compression technique using various polymers viz; Guar gum, Xanthan gum, ...
28
FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN
... The physical parameters of the floating tablets prepared are given in Table 2.Hardness of the tablets was in the range 4.0-5.0 Kg/cm 2 .Weight loss in the friability test was less than 0.85% in all the cases. All ...
13
DESIGN AND EVALUATION OF ONCE DAILY LOSARTAN POTASSIUM SUSTAINED RELEASE MATRIX TABLET
... of Losartan potassium and to evaluate its efficacy in reducing ...The evaluation involves three stages: the micromeritic properties evaluation of powder blend, physical property studies of ...
7
DEVELOPMENT EVALUATION AND CHARACTERIZATION OF LOSARTAN POTASSIUM BUCCAL PATCHES USING HYDROPHILIC POLYMERS
... development, evaluation and characterization of buccal patches of losartan potassium using mucoadhesive hydrophilic polymers such as fenugreek seed mucilage (FSM), tamarind seed polysaccharide (TSP), ...
11
Formulation, Development and Evaluation of Floating Microsphere of Losartan Potassium Using Natural Polymer
... > 1.0 super case II transport is apparent. ‘n’ is the slope value of log M t /M ∞ versus log time curve 16 . Stability studies for optimized formulation Accelerated testing, are the studies designed to amplify the rate ...
6
FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM COMPRESSION COATED TABLETS BY OKRA GUM AS A BINDER
... physicochemical parameters and pharmacokinetic behavior of drugs, route of administration, disease state to be treated and most important placement of the drug in the dosage form that will provide the desired ...
6
Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium
... Losartan potassium is an angiotensin antagonist, which has been reported to lower the blood pressure without disrupting the diurnal variation in hypertensive ...of losartan potassium which can ...
6
DESIGN AND EVALUATION OF LOSARTAN POTASSIUM CHRONOMODULATED DELIVERY SYSTEM FOR EFFECTIVE THERAPY OF HYPERTENSION
... to evaluation of various parameters like thickness, hardness, weight variation, friability, disintegration time, percentage drug content, water uptake and erosion studies, in vitro drug release studies, ...
11
Human bioequivalence evaluation of two losartan potassium tablets under fasting conditions
... Two Losartan Potassium Tablets Under Fasting The bioequivalence of two different tablet formulations containing losartan potassium 100 mg was determined in healthy volunteers after a single ...
6